222 related articles for article (PubMed ID: 32446935)
1. ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation.
Jones BE; Herrera CA; Agosto-Burgos C; Starmer J; Bass WA; Poulton CJ; Blazek L; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Wu EY; Chen DP; Jennette JC; Free ME; Falk RJ; Ciavatta DJ
Kidney Int; 2020 Sep; 98(3):744-757. PubMed ID: 32446935
[TBL] [Abstract][Full Text] [Related]
2. Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Yang J; Ge H; Poulton CJ; Hogan SL; Hu Y; Jones BE; Henderson CD; McInnis EA; Pendergraft WF; Jennette JC; Falk RJ; Ciavatta DJ
Clin Epigenetics; 2016; 8():85. PubMed ID: 27752292
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of autoantigen genes in ANCA-associated vasculitis involves alternative transcripts and new protein synthesis.
McInnis EA; Badhwar AK; Muthigi A; Lardinois OM; Allred SC; Yang J; Free ME; Jennette JC; Preston GA; Falk RJ; Ciavatta DJ
J Am Soc Nephrol; 2015 Feb; 26(2):390-9. PubMed ID: 25060059
[TBL] [Abstract][Full Text] [Related]
4. Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis.
Jones BE; Yang J; Muthigi A; Hogan SL; Hu Y; Starmer J; Henderson CD; Poulton CJ; Brant EJ; Pendergraft WF; Jennette JC; Falk RJ; Ciavatta DJ
J Am Soc Nephrol; 2017 Apr; 28(4):1175-1187. PubMed ID: 27821628
[TBL] [Abstract][Full Text] [Related]
5. PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease.
Chen DP; Aiello CP; McCoy D; Stamey T; Yang J; Hogan SL; Hu Y; Derebail VK; Wu EY; Jennette JC; Falk RJ; Ciavatta DJ
JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36626226
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis.
Ciavatta DJ; Yang J; Preston GA; Badhwar AK; Xiao H; Hewins P; Nester CM; Pendergraft WF; Magnuson TR; Jennette JC; Falk RJ
J Clin Invest; 2010 Sep; 120(9):3209-19. PubMed ID: 20714105
[TBL] [Abstract][Full Text] [Related]
7. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
8. CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens.
Tarzi RM; Liu J; Schneiter S; Hill NR; Page TH; Cook HT; Pusey CD; Woollard KJ
Clin Exp Immunol; 2015 Jul; 181(1):65-75. PubMed ID: 25766482
[TBL] [Abstract][Full Text] [Related]
9. Competitively disrupting the neutrophil-specific receptor-autoantigen CD177:proteinase 3 membrane complex reduces anti-PR3 antibody-induced neutrophil activation.
Marino SF; Jerke U; Rolle S; Daumke O; Kettritz R
J Biol Chem; 2022 Mar; 298(3):101598. PubMed ID: 35063507
[TBL] [Abstract][Full Text] [Related]
10. Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies.
O'Brien EC; Abdulahad WH; Rutgers A; Huitema MG; O'Reilly VP; Coughlan AM; Harrington M; Heeringa P; Little MA; Hickey FB
Sci Rep; 2015 Jul; 5():11888. PubMed ID: 26149790
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Harper L; Cockwell P; Adu D; Savage CO
Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
[TBL] [Abstract][Full Text] [Related]
12. Saint John on Patmos: Revelations of the Role of Antineutrophil Cytoplasmic Antibody (ANCA) in Vasculitis.
Pijnappel EN; Rijkers GT; Overveld FJV
Curr Med Chem; 2020; 27(17):2852-2862. PubMed ID: 31838986
[TBL] [Abstract][Full Text] [Related]
13. Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils.
Hess C; Sadallah S; Schifferli JA
Blood; 2000 Oct; 96(8):2822-7. PubMed ID: 11023517
[TBL] [Abstract][Full Text] [Related]
14. Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis.
Muller Kobold AC; Kallenberg CG; Tervaert JW
Br J Rheumatol; 1998 Aug; 37(8):901-7. PubMed ID: 9734683
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fcgamma receptor ligation.
Ben-Smith A; Dove SK; Martin A; Wakelam MJ; Savage CO
Blood; 2001 Sep; 98(5):1448-55. PubMed ID: 11520794
[TBL] [Abstract][Full Text] [Related]
16. Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils.
Hsieh SC; Yu HS; Cheng SH; Li KJ; Lu MC; Wu CH; Tsai CY; Yu CL
Clin Rheumatol; 2007 Feb; 26(2):216-24. PubMed ID: 16575489
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor is involved in antineutrophil cytoplasmic antibody-mediated activation of C5a-primed neutrophils.
Hao J; Lv T; Xu L; Ran M; Wu K
BMC Immunol; 2019 Jun; 20(1):22. PubMed ID: 31248381
[TBL] [Abstract][Full Text] [Related]
18. Targeting Cathepsin C in PR3-ANCA Vasculitis.
Jerke U; Eulenberg-Gustavus C; Rousselle A; Nicklin P; Kreideweiss S; Grundl MA; Eickholz P; Nickles K; Schreiber A; Korkmaz B; Kettritz R
J Am Soc Nephrol; 2022 May; 33(5):936-947. PubMed ID: 35292437
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
20. Protective α1-antitrypsin effects in autoimmune vasculitis are compromised by methionine oxidation.
Ebert M; Jerke U; Eulenberg-Gustavus C; Kling L; Jenne D; Kirchner M; Mertins P; Bieringer M; Elitok S; Eckardt KU; Schreiber A; Salama AD; Kettritz R
J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36125911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
